Kineta Inc - Margin dodolan resik KA

Tandha merek Kineta (KA)

The net margin of trading and production activities for Kineta, Inc. (KA) with the 0.00 metric demonstrates the effect of outsourcing production to US contractors. This trend is driven by the platform's potential to combat "cold" tumors and the prospects of an acquisition by pharma behemoths. However, the current trend is constrained by a freeze on new tests to preserve liquidity and a shift toward passive patent management.

Kineta, Inc. (KA) - Margin resik saka 28.04.2023 nganti 28.09.2024

KA (Kineta Corp): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:Kineta Corp, KA
Barang unggulan Kineta Bio

Institutional capital evaluates Kineta, Inc. (KA) shares through the lens of revenue-to-net-income conversion efficiency. This metric measures the portion of profit remaining after all operating and tax expenses. By analyzing the net profit margin chart, an investor determines the business's financial resilience. For the biotechnology sector, this reflects the impact of ESG standard costs and biomaterial disposal. Steady growth in this metric confirms the asset's reliability.

Analisis perusahaan pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|NXTC - Rentabilitas dodolan miturut bathi resik|LPTX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Rentabilitas dodolan miturut bathi resik|Synthetic Biologics (TOVX) - Margin dodolan resik|Margin resik Gritstone bio|Rentabilitas dodolan resik NEXI (NexImmune Corp)|Margin dodolan resik TSBX|VCNX (Vaccinex, Inc.) - Tingkat bathi resik|Margin dodolan resik HARP (Harpoon Therapeutics, Inc.)